Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin increased, Haematocrit, Haemoglobin, High density lipoprotein, Investigation
Clinical narrative: Hgb A1c: 5.8; Ref. Range: 4.7 - 5.6; Alb/Glob: 1.8; Ref. Range: 0.8 - 1.6; This is a spontaneous report received from contactable reporter(s) (Physician and Nurse).  A 76-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 07Sep2022 as dose 5 (booster), single (Lot number: 6H9694) at the age of 75 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose: 1; Anatomical site of injection: Unknown, Route of administration: Intramuscular, Batch/Lot number: EL3246), administration date: 19Jan2021, when the patient was 74-year-old, for COVID-19 immunization, reaction(s): "COVID-19"; BNT162b2 (Dose: 2, Anatomical site of injection: Unknown, Route of administration: Intramuscular, Batch/Lot number: EL9262), administration date: 09Feb2021, when the patient was 74-year-old, for COVID-19 immunization, reaction(s): "COVID-19"; BNT162b2 (Dose: 3, Anatomical site of injection: Unknown, Route of administration: Intramuscular, Batch/Lot number: FF3587), administration date: 24Sep2021, when the patient was 74-year-old, for COVID-19 immunization, reaction(s): "COVID-19"; BNT162b2 (Dose:4, Batch/Lot number: FJ4489), administration date: 22Apr2022, when the patient was 75-year-old, for COVID-19 immunization, reaction(s): "COVID-19". The following information was reported: GLYCOSYLATED HAEMOGLOBIN INCREASED (non-serious), outcome "unknown", described as "Hgb A1c: 5.8; Ref. Range: 4.7 - 5.6"; ALBUMIN GLOBULIN RATIO INCREASED (non-serious), outcome "unknown", described as "Alb/Glob: 1.8; Ref. Range: 0.8 - 1.6". The patient underwent the following laboratory tests and procedures: Alanine aminotransferase (0-55): (06Dec2022) 22, notes: Ref. Range: 0-55; Albumin globulin ratio (0.8-1.6): (06Dec2022) 1.8 (H), notes: Ref. Range: 0.8-1.6; Anion gap (5-16): (06Dec2022) 9, notes: Ref. Range: 5-16; Aspartate aminotransferase (5-34): (06Dec2022) 21, notes: Ref. Range: 5-34; Basophil count (0.0-2.0): (06Dec2022) 1.0, notes: Ref. Range: 0.0-.2.0; Basophil count (0.0-0.2): (06Dec2022) 0.0, notes: Ref. Range: 0.0-0.2; Blood albumin (3.5-5.0): (06Dec2022) 4.4, notes: Ref. Range: 3.5-5.0; Blood alkaline phosphatase (40-150): (06Dec2022) 94, notes: Ref. Range: 40-150; Blood bilirubin (0.2-1.2): (06Dec2022) 0.4, notes: Ref. Range: 0.2-1.2; Blood calcium (8.5-10.5): (06Dec2022) 9.6, notes: Ref. Range: 8.5-10.5; Blood chloride (98-109): (06Dec2022) 108, notes: Ref. Range: 98-109; Blood cholesterol (120-199): (06Dec2022) 150, notes: Ref. Range: 120-199; Blood creatinine (0.300-1.300): (06Dec2022) 0.870, notes: Ref. Range: 0.300-1.300; Blood glucose: (06Dec2022) 120; Blood glucose (70-99): (06Dec2022) 96, notes: Ref. Range: 70-99; Blood potassium (3.5-5.1): (06Dec2022) 4.6, notes: Ref. Range: 3.5-5.1; Blood sodium (136-145): (06Dec2022) 142, notes: Ref. Range: 136-145; Blood thyroid stimulating hormone (0.358-3.740): (06Dec2022) 0.383, notes: Ref. Range: (0.358-3.740); Blood triglycerides: (06Dec2022) 131, notes: Ref. Range:<=149; Blood urea (6-26): (06Dec2022) 17, notes: Ref. Range: 6-26; Blood urea nitrogen/creatinine ratio (7-34): (06Dec2022) 20, notes: Ref. Range: 7-34; Carbon dioxide (21-32): (06Dec2022) 25, notes: Ref. Range: 21-32; Eosinophil count (0.0-6.0): (06Dec2022) 2.5, notes: Ref. Range: 0.0-6.0; Eosinophil count (0.0-0.4): (06Dec2022) 0.1, notes: Ref. Range: 0.0-0.4; Globulin (2.4-4.2): (06Dec2022) 2.4, notes: Ref. Range: 2.4-4.2; Glomerular filtration rate: (06Dec2022) Unknown results; (06Dec2022) >60; (06Dec2022) Unknown results; Glycosylated haemoglobin (4.7-5.6): (06Dec2022) 5.8 (H), notes: Ref. Range: 4.7-5.6; Haematocrit (37.0-47.0): (06Dec2022) 38.7, notes: Ref. Range: 37.0-47.0; Haemoglobin (12.0-16.0): (06Dec2022) 13.1, notes: Ref. Range: 12.0-16.0; High density lipoprotein: (06Dec2022) 41, notes: Ref. Range: >=40-; AKI Suspected: (06Dec2022) NA; Risk Ratio (0.00-3.50): (06Dec2022) 3.66 (H), notes: Ref. Range: 0.00-3.50; Segs (45.0-75.0): (06Dec2022) 59.6, notes: Ref. Range: 45.0-75.0; Lipids: (06Dec2022) Unknown results; Low density lipoprotein (0-99): (06Dec2022) 83, notes: Ref. Range: 0-99; Lymphocyte count (0.7-4.0): (06Dec2022) 1.4, notes: Ref. Range: 0.7-4.0; Lymphocyte count (24.0-44.0): (06Dec2022) 28.3, notes: Ref. Range: 24.0-44.0; Mean cell haemoglobin (26.0-32.0): (06Dec2022) 31.1, notes: Ref. Range: 26.0-32.0; Mean cell haemoglobin concentration (31.0-36.0): (06Dec2022) 33.7, notes: Ref. Range: 31.0-36.0; Mean cell volume (80.0-100.0): (06Dec2022) 92.2, notes: Ref. Range: 80.0-100.0; Mean platelet volume (6.5-13.0): (06Dec2022) 9.7, notes: Ref. Range: 6.5-13.0; Monocyte count (0.0-10.0): (06Dec2022) 8.6, notes: Ref. Range: 0.0-10.0; Monocyte count (0.0-0.8): (06Dec2022) 0.4, notes: Ref. Range: 0.0-0.8; Neutrophil count (1.4-8.5): (06Dec2022) 3.0, notes: Ref. Range: 1.4-8.5; Platelet count (140-450): (06Dec2022) 212, notes: Ref. Range: 140-450; Protein total (6.4-8.2): (06Dec2022) 6.8, notes: Ref. Range: 6.4-8.2; Red blood cell count (3.60-5.40): (06Dec2022) 4.20, notes: Ref. Range: 3.60-5.40; Red cell distribution width (11.5-14.5): (06Dec2022) 12.8, notes: Ref. Range: 11.5-14.5; Vitamin D (30.0-100.0): (06Dec2022) 46.1, notes: Ref. Range: 30.0-100.0; White blood cell count (4.5-11.0): (06Dec2022) 5.0, notes: Ref. Range: 4.5-11.0.